Atara Biotherapeutics, Inc.
ATRA
$14.10
$1.5512.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.30M | 2.39M | 38.01M | -12.69M | -21.91M |
| Total Depreciation and Amortization | -964.00K | 236.00K | 1.80M | 1.10M | 1.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.36M | 2.83M | 14.17M | 9.53M | 10.13M |
| Change in Net Operating Assets | -7.88M | -12.77M | -82.11M | -22.41M | 6.56M |
| Cash from Operations | -9.79M | -7.32M | -28.14M | -24.47M | -3.99M |
| Capital Expenditure | -- | -- | -- | -90.00K | 0.00 |
| Sale of Property, Plant, and Equipment | 44.00K | 349.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.47M | -5.42M | 17.20M | 3.47M | -16.67M |
| Cash from Investing | -2.42M | -5.07M | 17.20M | 3.38M | -16.67M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -250.00K | -235.00K | -197.00K |
| Issuance of Common Stock | 1.51M | 1.00K | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -93.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -461.00K | 15.30M | -- | 0.00 | 35.99M |
| Cash from Financing | 1.05M | 15.30M | -250.00K | -328.00K | 35.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.16M | 2.92M | -11.19M | -21.42M | 15.14M |